- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Critical COVID-19 With Respiratory Failure in Poland
Total 256 results
-
AstraZenecaCompletedCOVID-19United States, Spain, United Kingdom, Brazil, Germany, Ukraine, Japan, Italy, Poland, Russian Federation, Mexico, Czechia, Argentina, Hungary, Peru
-
Gilead SciencesCompletedCOVID-19United States, Spain, United Kingdom, Hong Kong, Taiwan, Italy, France, Korea, Republic of, Switzerland, Germany, Netherlands, Singapore, Sweden, China, Japan
-
PfizerCompletedCOVID-19United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
-
Regeneron PharmaceuticalsTerminatedImmunocompromisedUnited States, Mexico
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Japan, Mexico, Singapore, Korea, Republic of
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19Korea, Republic of, United States, Denmark, Japan, Mexico, Singapore, Spain, United Kingdom
-
Merck Sharp & Dohme LLCCompletedPapillomavirus Infections | Coronavirus Disease (COVID-19)United States
-
Gilead SciencesCompletedCOVID-19United States, Japan
-
Dr. Jurjan AmanExvastat Ltd.; Simbec-Orion Group; KABS laboratoriesTerminatedCovid19 | Endothelial Dysfunction | Acute Respiratory Distress Syndrome | ARDS | Pulmonary EdemaNetherlands
-
NovavaxDepartment of Health and Human ServicesCompletedCovid19 | SARS-CoV InfectionUnited States, Mexico, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaboratorsCompletedCovid19 | CoronavirusUnited States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
-
Eli Lilly and CompanyCompletedCOVID-19United States, Spain, India, Germany, Puerto Rico, Brazil, Korea, Republic of, Argentina, Italy, Japan, Mexico, Russian Federation, United Kingdom
-
BioNTech SEPfizerActive, not recruiting
-
Regeneron PharmaceuticalsCompleted
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Brazil, South Africa, Germany, Canada, Israel
-
NovavaxActive, not recruitingCOVID-19Spain, United States, South Africa, Mexico, United Kingdom, Philippines, Colombia, Dominican Republic, Guatemala, Honduras
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Regeneron PharmaceuticalsCompletedHealthy ParticipantsUnited States, Moldova, Republic of, Romania
-
PfizerTerminatedCOVID-19United States, Malaysia, Thailand, Turkey, Spain, Czechia, Poland, Bulgaria, Japan, Korea, Republic of, South Africa, Hungary, Argentina, Brazil, Colombia, Mexico, Puerto Rico, Romania, Slovakia, Ukraine
-
AstraZenecaIqvia Pty LtdCompletedCOVID-19United States, Belgium, France, Spain, United Kingdom
-
Regeneron PharmaceuticalsCompletedCOVID-19United States, Mexico, Romania, Brazil, Chile, Moldova, Republic of
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
PfizerRecruitingCOVID-19United States, United Kingdom, Mexico, South Africa, Japan, Bulgaria, Hungary, Puerto Rico
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Vir Biotechnology, Inc.GlaxoSmithKlineCompletedCovid19United States, Canada, Spain, Austria, Brazil, Peru, United Kingdom
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Completed
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
Partner Therapeutics, Inc.United States Department of DefenseCompletedCovid19 | SARS-CoV InfectionUnited States, Argentina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | COVID-19 Infection | Hereditary Breast CarcinomaUnited States
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Active, not recruiting
-
Susanna Naggie, MDVanderbilt University Medical Center; National Center for Advancing Translational...Active, not recruiting
-
BioNTech SEPfizerCompletedCOVID-19 | Influenza, HumanUnited States
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV2 InfectionUnited States, Puerto Rico
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 Infection | Maternal ImmunizationUnited States, United Kingdom, Spain, Brazil, South Africa
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); Gilead Sciences; University... and other collaboratorsCompleted
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedSARS-CoV Infection | Coronavirus | Acute Respiratory InfectionUnited States
-
Ansun Biopharma, Inc.RecruitingCOVID-19 | Lower Respiratory Tract Infection | Immunocompromised | ParainfluenzaUnited States, Australia, China, Denmark, France, Hong Kong, Korea, Republic of, Taiwan
-
Thomas L. OrtelNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSARS-CoV-2 InfectionUnited States
-
Regeneron PharmaceuticalsSanofiCompletedCOVID-19United States
-
BioNTech SEPfizerRecruitingCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | SARS-CoV-2 VirusUnited States, South Africa, Brazil, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...CompletedSARS-CoV-2 InfectionUnited States
-
Frank C SciurbaNational Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Gilead SciencesApproved for marketingSARS-CoV2 InfectionUnited States, Israel, Belgium, Spain, Australia, Denmark, Italy, Germany, France, Portugal, United Kingdom, Poland, Switzerland, Canada, Austria, Cyprus, Czechia, Estonia, Greece, Hungary, Iceland, Ireland, Lithuania, Netherlands, Romania and more
-
Massachusetts General HospitalCompletedSepsis | Critical Illness | Respiratory Failure | Acute Respiratory Distress SyndromeUnited States